EcoR1 Capital, LLC → GALAPAGOS NV GLPGF

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

7 filings by this filer

6 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 999.99

169,485 shares short · +153.3% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

2 holders · $22.51M

Greenlight CapitalPoint72 Asset Mgmt

Other 13D/G Filings on GALAPAGOS NV

Filed	Form	Filer	Stake	Shares
2025-01-10	SCHEDULE	GILEAD SCIENCES, INC.	29.90%	20,981,010	view →

Other Filings by EcoR1 Capital, LLC

Filed	Form	Issuer	Stake	Shares
2025-03-17	SCHEDULE	Zymeworks Inc. ZYME	24.20%	16,858,418	view →
2025-02-18	SCHEDULE	Zymeworks Inc. ZYME	22.80%	15,720,161	view →
2025-01-13	SCHEDULE	Zymeworks Inc. ZYME	22.40%	15,411,078	view →
2025-01-03	SCHEDULE	PROTHENA CORP PUBLIC LTD CO PRTA	21.50%	11,584,280	view →
2021-05-11	SC	ANAPTYSBIO, INC ANABV	—	—	view →
2021-04-13	SC	ANAPTYSBIO, INC ANABV	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →